232 related articles for article (PubMed ID: 2472488)
1. Human biologic response modification by interferon in the absence of measurable serum concentrations: a comparative trial of subcutaneous and intravenous interferon-beta serine.
Goldstein D; Sielaff KM; Storer BE; Brown RR; Datta SP; Witt PL; Teitelbaum AP; Smalley RV; Borden EC
J Natl Cancer Inst; 1989 Jul; 81(14):1061-8. PubMed ID: 2472488
[TBL] [Abstract][Full Text] [Related]
2. A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans.
Schiller JH; Storer B; Paulnock DM; Brown RR; Datta SP; Witt PL; Borden EC
J Clin Invest; 1990 Oct; 86(4):1211-21. PubMed ID: 2120284
[TBL] [Abstract][Full Text] [Related]
3. Biological and clinical effects of the combination of beta- and gamma-interferons administered as a 5-day continuous infusion.
Schiller JH; Storer B; Witt PL; Nelson B; Brown RR; Horisberger M; Grossberg S; Borden EC
Cancer Res; 1990 Aug; 50(15):4588-94. PubMed ID: 2114942
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of recombinant human interferon-beta ser in healthy volunteers and its effect on serum neopterin.
Chiang J; Gloff CA; Yoshizawa CN; Williams GJ
Pharm Res; 1993 Apr; 10(4):567-72. PubMed ID: 8483840
[TBL] [Abstract][Full Text] [Related]
5. Biological and clinical effects of interferon-beta ser at two doses.
Borden EC; Rinehart JJ; Storer BE; Trump DL; Paulnock DM; Teitelbaum AP
J Interferon Res; 1990 Dec; 10(6):559-70. PubMed ID: 2086672
[TBL] [Abstract][Full Text] [Related]
6. Clinical and biological effects of recombinant interferon-beta administered intravenously daily in phase I trial.
Borden EC; Hawkins MJ; Sielaff KM; Storer BM; Schiesel JD; Smalley RV
J Interferon Res; 1988 Jun; 8(3):357-66. PubMed ID: 3045221
[TBL] [Abstract][Full Text] [Related]
7. A phase I study of recombinant interferon-beta in patients with advanced malignant disease.
Ravandi F; Estrov Z; Kurzrock R; Breitmeyer JB; Maschek BJ; Talpaz M
Clin Cancer Res; 1999 Dec; 5(12):3990-8. PubMed ID: 10632330
[TBL] [Abstract][Full Text] [Related]
8. Absence of biological effects of orally administered interferon-beta ser.
Witt PL; Goldstein D; Storer BE; Grossberg SE; Flashner M; Colby CB; Borden EC
J Interferon Res; 1992 Dec; 12(6):411-3. PubMed ID: 1289408
[TBL] [Abstract][Full Text] [Related]
9. Double-blind randomized phase I study on the clinical tolerance and pharmacodynamics of natural and recombinant interferon-beta given intravenously.
Liberati AM; Garofani P; De Angelis V; Di Clemente F; Horisberger M; Cecchini M; Betti AR; Palmisano L; Astolfi S; Nastari A
J Interferon Res; 1994 Apr; 14(2):61-9. PubMed ID: 8077767
[TBL] [Abstract][Full Text] [Related]
10. Prolonged interferon-gamma application by subcutaneous infusion in cancer patients: differential response of serum CD14, neopterin, and monocyte HLA class I and II antigens.
Landmann R; Ludwig C; Wesp M; Fisscher A; Obrist R; Knüsli C; Denz H; Obrecht JP
J Interferon Res; 1992 Apr; 12(2):103-11. PubMed ID: 1374454
[TBL] [Abstract][Full Text] [Related]
11. Phase I trial of an oral immunomodulator and interferon inducer in cancer patients.
Witt PL; Ritch PS; Reding D; McAuliffe TL; Westrick L; Grossberg SE; Borden EC
Cancer Res; 1993 Nov; 53(21):5176-80. PubMed ID: 8221654
[TBL] [Abstract][Full Text] [Related]
12. Induced proteins in human peripheral mononuclear cells over a range of clinically tolerable doses of interferon-gamma.
Paulnock DM; Havlin KA; Storer BM; Spear GT; Sielaff KM; Borden EC
J Interferon Res; 1989 Aug; 9(4):457-73. PubMed ID: 2502586
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics of recombinant IFN-beta during long-term treatment of malignant melanoma.
Fierlbeck G; Ulmer A; Schreiner T; Stroebel W; Schiebel U; Brzoska J
J Interferon Cytokine Res; 1996 Oct; 16(10):777-81. PubMed ID: 8910762
[TBL] [Abstract][Full Text] [Related]
14. Phase I/II trial of interferon-beta-serine in patients with renal cell carcinoma: immunological and biological effects.
Rinehart JJ; Young D; Laforge J; Colborn D; Neidhart JA
Cancer Res; 1987 May; 47(9):2481-5. PubMed ID: 3567933
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of recombinant human interferon-beta in healthy male volunteers.
Salmon P; Le Cotonnec JY; Galazka A; Abdul-Ahad A; Darragh A
J Interferon Cytokine Res; 1996 Oct; 16(10):759-64. PubMed ID: 8910759
[TBL] [Abstract][Full Text] [Related]
16. [Changes in serum levels of beta 2-microglobulin, neopterin and 2',5'-oligoadenylate synthase activity during clearance of hepatitis B virus with or without acute phase in transaminases].
Carreño García V; Hernández-Guío C; Bartolomé Nebreda J; Quiroga Estévez JA
Rev Esp Enferm Dig; 1993 Mar; 83(3):169-75. PubMed ID: 7683894
[TBL] [Abstract][Full Text] [Related]
17. Determination of 2'-5'-oligoadenylate synthetase in serum and peripheral blood mononuclear cells before and after subcutaneous application of recombinant interferon beta and gamma.
Bruchelt G; Fierlbeck G; Schiebel U; Bogenschütz O; Rassner G; Niethammer D
Eur J Clin Chem Clin Biochem; 1992 Sep; 30(9):521-8. PubMed ID: 1457613
[TBL] [Abstract][Full Text] [Related]
18. 2',5'-oligoadenylate synthetase, neopterin and beta 2-microglobulin in asymptomatic HIV-infected individuals.
Witt PL; Spear GT; Lindstrom MJ; Kessler HA; Borden EC; Phair J; Landay AL
AIDS; 1991 Mar; 5(3):289-93. PubMed ID: 2059368
[TBL] [Abstract][Full Text] [Related]
19. Clinical and biologic effects of combination therapy with gamma-interferon and tumor necrosis factor.
Schiller JH; Witt PL; Storer B; Alberti D; Tombes MB; Arzoomanian R; Brown RR; Proctor RA; Voss SD; Spriggs DR
Cancer; 1992 Jan; 69(2):562-71. PubMed ID: 1728387
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics of biological response in vivo after single and multiple doses of interferon-beta.
Witt PL; Storer BE; Bryan GT; Brown RR; Flashner M; Larocca AT; Colby CB; Borden EC
J Immunother Emphasis Tumor Immunol; 1993 Apr; 13(3):191-200. PubMed ID: 8471593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
